Advertisement

Month: March 2020

February 2020 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Gefapixant Promising for Relief of Unexplained Chronic Cough […]

Read More

February 2020 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Varenicline Seems Safe for Adults Without Depression FRIDAY, […]

Read More

February 2020 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Inflammatory Conditions of Skin, Bowel May Be Linked […]

Read More

February 2020 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Certified Medical Homes Tied to Better […]

Read More

February 2020 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Vitamin D Tied to Back Problems in […]

Read More

February 2020 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Inflammatory Conditions of Skin, Bowel May Be Linked […]

Read More

February 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. HIV-Infected Youth Less Likely to Achieve […]

Read More

February 2020 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. HIV-Infected Youth Less Likely to Achieve Viral […]

Read More

February 2020 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Age of Onset May Affect Clinical Outcomes for […]

Read More

February 2020 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Assisting Medication Continuity Cuts Readmissions for Seniors FRIDAY, […]

Read More

February 2020 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Vitamin D Tied to Back […]

Read More

February 2020 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Statin Use May Reduce Mortality in […]

Read More

February 2020 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Eye Movement Training Efficacious for Hemianopic Patients FRIDAY, […]

Read More

February 2020 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Vitamin D Tied to Back Problems in Postmenopausal […]

Read More

February 2020 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. HIV-Infected Youth Less Likely to Achieve Viral Suppression […]

Read More

February 2020 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for February 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Varenicline Seems Safe for Adults Without Depression FRIDAY, […]

Read More

For latest news and updates
Email-id is invalid